GSA Capital Partners LLP Takes Position in Assertio Holdings, Inc. (NASDAQ:ASRT)

GSA Capital Partners LLP acquired a new position in shares of Assertio Holdings, Inc. (NASDAQ:ASRT) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 149,968 shares of the company’s stock, valued at approximately $177,000.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Point72 DIFC Ltd acquired a new position in Assertio during the 2nd quarter worth approximately $40,000. Thurston Springer Miller Herd & Titak Inc. raised its position in shares of Assertio by 304.0% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 50,500 shares of the company’s stock valued at $60,000 after buying an additional 38,000 shares in the last quarter. Marshall Wace LLP acquired a new stake in shares of Assertio in the 2nd quarter valued at approximately $70,000. Los Angeles Capital Management LLC bought a new position in Assertio in the second quarter valued at about $77,000. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Assertio in the second quarter worth $149,000. Institutional investors and hedge funds own 48.96% of the company’s stock.

Insider Activity

In other news, Director Heather L. Mason bought 75,000 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The shares were bought at an average cost of $0.80 per share, for a total transaction of $60,000.00. Following the completion of the transaction, the director now owns 287,650 shares of the company’s stock, valued at approximately $230,120. This represents a 35.27 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 3.20% of the company’s stock.

Assertio Price Performance

Shares of Assertio stock opened at $0.94 on Monday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.57 and a current ratio of 2.01. Assertio Holdings, Inc. has a 52-week low of $0.73 and a 52-week high of $1.80. The stock has a market capitalization of $89.83 million, a price-to-earnings ratio of -1.29 and a beta of 0.83. The company has a fifty day moving average of $1.08 and a 200-day moving average of $1.17.

Assertio (NASDAQ:ASRT) last announced its earnings results on Monday, November 11th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.05) by $0.02. Assertio had a positive return on equity of 3.79% and a negative net margin of 54.46%. The firm had revenue of $29.20 million during the quarter, compared to analyst estimates of $29.29 million. During the same quarter in the prior year, the company earned ($0.01) EPS. Equities research analysts expect that Assertio Holdings, Inc. will post -0.17 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded Assertio from a “hold” rating to a “buy” rating in a research note on Wednesday, November 13th.

Assertio Company Profile

Assertio Holdings, Inc, a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.